Last reviewed · How we verify
Adipinic Acid (adipic acid)
Adipinic Acid (generic name: adipic acid) is a adipic acid drug. It is currently in unknown development.
Adipic acid works by being converted into a polymer, which is then used to create synthetic materials.
Adipic acid is a small molecule drug of the adipic acid class, but it is not a pharmaceutical drug. It is a dicarboxylic acid used as a precursor in the production of nylon and other polyamides. The original developer and current owner of adipic acid are not specified in the provided facts. Adipic acid is not FDA-approved for any indications and its commercial status, safety considerations, and pharmacokinetic properties are unknown. As a result, there is no information available on its use as a pharmaceutical agent.
At a glance
| Generic name | adipic acid |
|---|---|
| Drug class | adipic acid |
| Target | Solute carrier family 22 member 6 |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body is like a factory that builds things. Adipic acid is a raw material that gets converted into a long chain of molecules, kind of like a big Lego structure. This chain is then used to make synthetic materials like nylon, which is used in clothing and other products.
Approved indications
Common side effects
Key clinical trials
- Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant (PHASE1)
- Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women (PHASE3)
- Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers (NA)
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation (PHASE2)
- A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD) (PHASE2)
- Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies (PHASE1)
- Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease (PHASE1)
- Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adipinic Acid CI brief — competitive landscape report
- Adipinic Acid updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Adipinic Acid
What is Adipinic Acid?
How does Adipinic Acid work?
What is the generic name of Adipinic Acid?
What drug class is Adipinic Acid in?
What development phase is Adipinic Acid in?
What does Adipinic Acid target?
Related
- Drug class: All adipic acid drugs
- Target: All drugs targeting Solute carrier family 22 member 6
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing